Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Clofutriben + prednisolone) by Sparrow Pharmaceuticals for Polymyalgia Rheumatica (PMR): Likelihood of Approval
(Clofutriben + prednisolone) is under clinical development by Sparrow Pharmaceuticals and currently in Phase II for Polymyalgia Rheumatica (PMR). According...